LeMaitre Vascular (LMAT) will increase its quarterly dividend by 21.4 percent to $0.085 per share in the first quarter of 2019. This follows double digit dividend increases in each of the previous seven years by the medical devices maker.

The increased dividend will be paid April 5, 2019 to shareholders of record on March 22, 2019. A new annualized dividend rate of 34 cents per share yields 1.4% at a stock price of $25.10 for LMAT.

LeMaitre Vascular, Inc.  is a global provider of medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. We develop, manufacture, and market vascular devices to address the needs of vascular surgeons. The company's portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and include the HYDRO Expandable LeMaitre Valvulotome, the XenoSure biologic patch, the Pruitt F3 Carotid Shunt and VascuTape Radiopaque Tape. The company's products are sold worldwide, primarily in the United States, Europe and, to a lesser extent, Asia and the Pacific Rim.